Researching Marijuana for Therapeutic Purposes: The Potential Promise of Cannabidiol (CBD)

By Nora Volkow, Director, National Institute on Drug Abuse

Three weeks ago I had the opportunity to testify before the Senate on cannabidiol, or CBD -- one of the main active ingredients in the marijuana plant, and a compound around which there is a growing amount of interest from the public as well as the scientific and medical communities. The intent of the hearing was to explore ways we can reduce obstacles to research on CBD, given that all chemicals in the marijuana plant are currently in the most restricted category of the Drug Enforcement Administration's schedule of controlled substances -- schedule I. This category is reserved for substances that have a high potential for abuse and no scientifically supported medical use. Medical research can and is being done with schedule I substances; however, there are strict regulations and administrative hurdles associated with this status.

The...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.huffingtonpost.com/nora-volkow/cannabidiol_b_7834066.html